
Clinical nephrology is confronted with an emerging medical catastrophy of international proportions; endstage renal failure in patients with type 2 diabetes. Based on a number of recent studies it has become apparent, that nephrology in type 2 diabetes is a preventable condition, at least in principle. It is for this reason that it appeared timely to summarize the current state of knowledge concerning nephropathy in type 2 diabetes giving an update on the predisposing factors on which interventions are of proven benefit and on the accepted standards of management of such patients. This concise monograph is addressed not only to nephrologists, but also diabetologists and general practitioners. It is hoped that it will help to improve clinical outcomes in the future.
This monograph investigates the clinical management and prevention of nephropathy in patients with type 2 diabetes, addressing the rising global incidence of end-stage renal failure. Eberhard Ritz and Ivan Rychlik, both established experts in the field of renal medicine, synthesize recent clinical studies to provide a framework for identifying predisposing factors. The text evaluates evidence-based interventions and establishes standardized protocols for practitioners to mitigate the progression of renal damage in diabetic populations.
What You Will Find
Scope Limits
Medical professionals frequently utilize this text as a foundational reference for integrating nephrology and diabetology practices. Experts highlight the clinical utility of the monograph for general practitioners seeking to improve patient outcomes through standardized management.
Page Count:
320
Publication Date:
2001-01-15
ISBN-10:
019262945X
ISBN-13:
9780192629456
No comments yet. Be the first to share your thoughts!